Financial News
Stories about Aimmune Therap
Benzinga's Top Upgrades, Downgrades For November 20, 2017
November 20, 2017
From Benzinga
35 Biggest Movers From Yesterday
October 23, 2017
From Benzinga
Aimmune Therapeutics Scores Relative Strength Rating Upgrade
October 23, 2017
Markets retreat ahead of Fed Chair nominee announcement
October 23, 2017
Tags
Market News
Benzinga's Option Alert Recap From October 23
October 23, 2017
From Benzinga
Monday's Biggest Mover: SenesTech's Stock Lifted More Than 80%
October 23, 2017
From Benzinga
Mid-Afternoon Market Update: Exactech Surges Following Acquisition News; Eldorado Gold Shares Drop
October 23, 2017
From Benzinga
From Motley Fool
32 Stocks Moving In Monday's Mid-Day Session
October 23, 2017
From Benzinga
Mid-Day Market Update: Petmed Express Climbs On Earnings Beat; DBV Technologies Shares Plunge
October 23, 2017
From Benzinga
From Benzinga
25 Stocks Moving In Monday's Pre-Market Session
October 23, 2017
From Benzinga
DBV Technologies Plunges By Half On Allergy Drug Trial's Failure
October 20, 2017
DBV Technologies peanut allergy drug fails key study
October 20, 2017
Tags
companyNews
Aimmune teams with Regeneron, Sanofi on peanut allergy drug
October 16, 2017
Tags
companyNews
Interesting AIMT Put And Call Options For November 17th
October 13, 2017
Tags
Stocks
From Market News Video
Notable Friday Option Activity: SPWR, CELG, AIMT
September 22, 2017
Tags
Stocks
From Market News Video
Notable Wednesday Option Activity: VSAR, AIMT, WFT
September 06, 2017
Tags
Stocks
From Market News Video
Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva
August 24, 2017
From Benzinga
Tags
companyNews
Tags
companyNews
Tags
companyNews
BRIEF-Aimmune Therapeutics reports on up-dosing in its ongoing phase 3 palisade trial of ar101 for peanut allergy
June 12, 2017
Tags
companyNews
BRIEF-CoreRx says co, Aimmune Therapeutics increased manufacturing operations in Florida
June 07, 2017
Tags
companyNews
Tags
Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.